Pfizer is considering offers from investors in a bid to spin off
its drug research and development laboratory in Japan and make it
an independent entity, according to media reports.
Averion has formed a new partnership in South America's clinical
trial hotspot Brazil - as it continues to tip-toe beyond North
America and Europe into emerging markets.
Two North American contract research organisation (CROs) have this
week announced acquisitive moves into emerging clinical trials
markets, while a third firm has extended an Asian partnership, as
the emerging market migration continues.
'Legislative chaos' has been preventing Poland from reaching its
full potential in the increasingly competitive central Eastern
European (CEE) region, although progress is being made.
etrials and Clinphone, two big players in the eclinical industry
are struggling to keep their heads above water as both companies'
recent woes have impacted their bottom line.
Russian contract research organisation (CRO) Synergy Research Group
has hooked up with a US-based CRO in a bid to expand its services
to North America.
Pfizer, among others, recently offered an insight into R&D
outsourcing in Japan, where this services market is still fairly
immature, with growth potential in several key areas.
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community this past week, involving Innovaderm
Research, Target Health, Qualia Clinical Service, and Quintiles.
PharmaNet has reported second quarter results that place it back in
the red after it had only just clawed its way back into the black
in the first quarter, following a string of quarterly losses.
PRA said it signed an agreement with equity firm Genstar Capital to
be bought back by the firm for around $790m (€580m) while the CRO
posted a 90 per cent tumble in profit in Q2 due to heavy
restructuring charges.
The total contract research organisation (CRO) market is expected
to reach $24bn (€18bn) by 2010 as biopharma companies' spending on
outsourcing services continues to soar, new research reveals.
Despite the hype, countries in emerging markets are still very much
trailing behind the US in the number of Food and Drug
Administration (FDA)-approved studies being conducted, particularly
the Asia-pacific, a survey by Parexel reveals.
PPD has posted positive financial results for the second quarter of
the year in net contrast to its lacklustre performance in Q1, but
cut its earning outlook for the full year.
Schering-Plough has licensed acadesine (AICA-riboside), a potential
first-in-class drug for the prevention of ischemia-reperfusion
injury from PeriCor Therapeutics to bolster its cardiac
therapeutics pipeline.
Parexel talks to Outsourcing-Pharma about its clinical research
experiences in emerging hot spot Latin America, as the contract
research organisation (CRO) has a presence in every country in this
continent that conducts international...
Quintiles is planning to spend $19m ($14m) to consolidate its US
central lab and its clinical services office in
Georgia to one location and expand capacity at the same
time.
One of the most significant deals to take place in the vaccine
industry in the last ten years was signed late last night between
vaccine heavyweight Novartis and biotech firm Intercell.
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community this past week, involving Encorium,
Amarex, Paragon Biomedical, Pacific Biometrics and Parexel.
India's Reliance Life Sciences (RLS) is planning an acquisition in
Europe or in the US joining the slow infiltration of Indian firms
cementing themselves in Western markets.
Pfizer has had its first day in a Nigerian court in a legal dispute
over its alleged involvement in the death of Nigerian children
during a clinical trial 11 years ago.
Just as the clinical trials sector in Russia is
starting to take off, the industry has been dealt a severe
blow with the sudden and indefinite banning of biological sample
exports.
The pharmaceutical and healthcare industries will help to push
trade between India and the United Kingdom up by 60 per cent within
three years, claims a soon-to-be released report.
Pfizer is facing fresh legal action from the Nigerian government
over its alleged involvement in the deaths of children it gave
an experimental drug to, more than a decade after the incident
occurred.
The first contract research service alliance (CROSA) in China has
been formed between three leading local firms to provide a more
exhaustive range of drug development services to pharma companies.
The significance of the aborted deal between GlaxoSmithKline and
Cobra has been exaggerated due to GSK's high profile and is not the
end of the world, the British contract manufacturer said.
Clinsys Clinical Research, BioReliance Corporation, InVentiv
Health, PRA International, Kendle, Parexel, PPD, Wyeth and
PharmaNet have all had people on the move in the world of
pharmaceutical outsourcing.
Outsourced pharmaceutical R&D spending is set to increase
at twice the expected rate of general R&D expenditure
for the next five years, according to new research published this
week.
US-based firm Goodwin Biotechnology said it is about to complete
the expansion of its biomanufacturing facility as the number of
contracts with biotech companies has jumped in the past two years.
Kendle has climbed back into the black in the first quarter of 2007
after another quarter of strong sales although pre-tax profit
remains down on 2006.
The pharma industry sees great opportunities in using Radio
Frequency Identification (RFID) technology during clinical trials,
a new survey has revealed.
Parexel has announced healthy financial results for its third
fiscal quarter, despite another disappointing performance in its
medical communications business.
A combination of different probiotics strains reduces the ability
of potentially pathogenic bacteria to colonise the gut more than
single strains, says new research that proposes industry should
look to expand research in this area.
It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...
The use of internal standards (IS) is essential for developing and applying liquid chromatography-tandem mass spectrometric (LC-MS/MS) quantitative bioanalytical...
A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...
